Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Kyung Heon Won"'
Autor:
Ji Eun Jun, In-Kyung Jeong, Jae Myung Yu, Sung Rae Kim, In Kye Lee, Kyung-Ah Han, Sung Hee Choi, Soo-Kyung Kim, Hyeong Kyu Park, Ji-Oh Mok, Yong-ho Lee, Hyuk-Sang Kwon, So Hun Kim, Ho-Cheol Kang, Sang Ah Lee, Chang Beom Lee, Kyung Mook Choi, Sung-Ho Her, Won Yong Shin, Mi-Seung Shin, Hyo-Suk Ahn, Seung Ho Kang, Jin-Man Cho, Sang-Ho Jo, Tae-Joon Cha, Seok Yeon Kim, Kyung Heon Won, Dong-Bin Kim, Jae Hyuk Lee, Moon-Kyu Lee
Publikováno v:
Diabetes & Metabolism Journal, Vol 44, Iss 1, Pp 78-90 (2020)
BackgroundCardiovascular risk remains increased despite optimal low density lipoprotein cholesterol (LDL-C) level induced by intensive statin therapy. Therefore, recent guidelines recommend non-high density lipoprotein cholesterol (non-HDL-C) as a se
Externí odkaz:
https://doaj.org/article/cf8166c8e475492aa9a22f443129bdf3
Autor:
Kyung-Jin Kim, Junghan Yoon, Kyung Heon Won, Sang-Wook Lim, In-Ho Chae, Sung Yun Lee, Sang-Wook Kim, Hyo-Soo Kim
Publikováno v:
Journal of Clinical Medicine, Vol 9, Iss 4, p 916 (2020)
The American College of Cardiology and American Heart Association (ACC/AHA) guidelines identified four statin benefit groups on the basis of atherosclerotic cardiovascular disease risk reduction and proposed statin therapy by evidence-based intensity
Externí odkaz:
https://doaj.org/article/d2977d0056924eb083ff69ec80339fe3
Autor:
In Kyung Jeong, Dong-Bin Kim, Mi-Seung Shin, Sang Ah Lee, Seung Ho Kang, Kyung Mook Choi, Moon Kyu Lee, Yong Ho Lee, Sung Hee Choi, Ji Eun Jun, Jae Hyuk Lee, Seok Yeon Kim, Jin Man Cho, Jae Myung Yu, Sung Rae Kim, Ho-Cheol Kang, Hyeong Kyu Park, Kyung Ah Han, Won-Yong Shin, Hyuk-Sang Kwon, Sung Ho Her, Ji Oh Mok, In Kye Lee, Kyung Heon Won, So Hun Kim, Soo Kyung Kim, Chang Beom Lee, Sang Ho Jo, Tae Joon Cha, Hyo Suk Ahn
Publikováno v:
Diabetes & Metabolism Journal
Diabetes & Metabolism Journal, Vol 44, Iss 1, Pp 78-90 (2020)
Diabetes & Metabolism Journal, Vol 44, Iss 1, Pp 78-90 (2020)
Background: Cardiovascular risk remains increased despite optimal low density lipoprotein cholesterol (LDL-C) level induced by intensive statin therapy. Therefore, recent guidelines recommend non-high density lipoprotein cholesterol (non-HDL-C) as a
Autor:
Sang Kon Lee, Joon-Han Shin, Jung Ho Heo, Jung Hyun Choi, Kyung Heon Won, Young Dae Kim, Jei Keon Chae, Jina Jung, Bum-Kee Hong, Myung Ho Jeong, Cheol Ho Kim, Dong Woon Kim, Kyoo Rok Han, Young Jin Choi, Hyun Jae Kang, Sang-Ho Park, Chang Gyu Park, Bong-Ki Lee, Seong Hoon Park, Jae Joong Kim, Ki Yuk Chang, Seung Uk Lee, Soon Jun Hong, Kee Sik Kim, Shung Chull Chae, Sang Hoon Kim, Woo Shik Kim, Han Saem Jeong, Kook Jin Chun, Jun Kwan, Seok Min Kang, Jung Rae Cho, Seung Hwan Han, Yu Jeong Choi, Dong Gu Shin
Publikováno v:
Clinical Therapeutics. 39:2049-2060
The goal of this study was to compare the efficacy and safety of fixed-dose combinations of amlodipine/losartan potassium/chlorthalidone (A/L/C) and A/L in Korean patients with stage 2 hypertension inadequately controlled by A/L.This study was an 8-w
Autor:
Seong-Hoon Lim, Jin-Ho Choi, Sung Yun Lee, Eul-Soon Im, Young Bin Song, Joo-Yong Hahn, Seung-Hyuk Choi, Kyung-Heon Won, Woo Jung Chun, Yong Hawn Park, Ju Hyeon Oh, Dae Kyoung Cho, Hyeon-Cheol Gwon, Sang Wook Kim, Jin-Ok Jeong, Yu Jeong Choi
Publikováno v:
International Journal of Cardiology. 240:114-119
Although coronary angiography is still the technique most widely used to guide percutaneous coronary intervention (PCI), the appropriate angiographic indication of revascularization for intermediate coronary lesions remains controversial. The aim of
Autor:
Hak-Jin Kim, Byung Ryul Cho, Jidong Sung, Sahng Lee, Jin Ok Jeong, Seung Woo Park, Byung Jin Kim, Kyung Heon Won, Jeong Euy Park, Seong-Hoon Lim, Sung Uk Kwon, Myeong Kon Kim
Publikováno v:
Korean Circulation Journal
Background and Objectives When monotherapy is inadequate for blood pressure control, the next step is either to continue monotherapy in increased doses or to add another antihypertensive agent. However, direct comparison of double-dose monotherapy ve
Autor:
Hyo-Soo Kim, Sang Wook Kim, Sang Wook Lim, In Ho Chae, Junghan Yoon, Kyung Heon Won, Sung Yun Lee, Kyung Jin Kim
Publikováno v:
Journal of Clinical Medicine, Vol 9, Iss 916, p 916 (2020)
Journal of Clinical Medicine
Volume 9
Issue 4
Journal of Clinical Medicine
Volume 9
Issue 4
The American College of Cardiology and American Heart Association (ACC/AHA) guidelines identified four statin benefit groups on the basis of atherosclerotic cardiovascular disease risk reduction and proposed statin therapy by evidence-based intensity
Autor:
Sang Hong Baek, Byung Hee Oh, Sang Wook Kim, Chang Gyu Park, Eun-Seok Shin, Dong-Ju Choi, Jun Kwan, Seung Uk Lee, Myung Ho Jeong, Jae Kean Ryu, Sung Hee John, Jae Joong Kim, Seung Hwan Lee, Sungha Park, Moo Yong Rhee, Woo Jung Park, Sung Yun Lee, Taehoon Ahn, Joon-Han Shin, Nam Ho Lee, Jae Hyeon Juhn, Yoon Nyun Kim, Jin Ok Jeong, Yu Jeong Lee, Kyung Heon Won, Taek Jong Hong, Jeong Cheon Ahn, Eun Seok Jeon, Dong Woon Kim, Sun-Young Kim, Moo Hyun Kim, Hae Young Lee, Sukkeun Hong, Jang Hyun Cho, Jin Ho Kang, Dong Hun Cha, Seong Wook Cho, Nam-Ho Kim, Sang Yong Yoo, Song-Yi Kim, Byung Soo Kim, Hui Kyung Jeon, Soon Kil Kim, Sang Hoon Na
Publikováno v:
Clinical Therapeutics. 37:1726-1739
The objective of this study was to evaluate the efficacy and safety of the lercanidipine/valsartan combination compared with lercanidipine monotherapy in patients with hypertension.Part 1 of this study was the randomized, multicenter, double-blind, p
Autor:
Dong Hun Cha, Hyo-Soo Kim, Ki Chul Sung, Dong Woon Jeon, Han Cheol Lee, Sang Kyoon Cho, Seung-Woon Rha, Weon Kim, Seok Yeon Kim, Moo Yong Rhee, Min Su Hyon, Wook Sung Chung, Han Saem Jeong, Kyung Heon Won, Joon-Han Shin, Byung Su Yoo, Jeong Cheon Ahn, Jang Ho Bae, Ki Dong Yoo, Jun Kwan, Kyoo Rok Han, Soon Jun Hong
Publikováno v:
Clinical Therapeutics. 40:226-241.e4
Combination therapy with ezetimibe and statins is recommended in cases of statin intolerance or insufficiency. The objective of this study was to compare the efficacy and safety of combination therapy with ezetimibe and rosuvastatin versus those of r
Autor:
Ki Chul Sung, Tack Jong Hong, Yu Jeong Choi, Dong Woon Jeon, Seung-Woon Rha, Jeong Cheon Ahn, Tae Hyun Yang, Min Su Hyon, Dong Hun Cha, Young Won Yoon, Sang-Hyun Kim, Ki Dong Yoo, Deok Kyu Cho, Byung Su Yoo, Jong Min Song, Soon Jun Hong, Sang Kyoon Cho, Byung Soo Kim, Sang-Ho Park, In Ho Chae, Young Keun Ahn, Ji Hun Ahn, Ji Yong Jang, Chang-Wook Nam, Hyo-Soo Kim, Yong Seog Oh, Kyung Heon Won, Jin Ok Jeong
Publikováno v:
Clinical Therapeutics. 40:50-63.e3
This 8-week study in Korea aimed to evaluate the efficacy and tolerability of a telmisartan/amlodipine + hydrochlorothiazide (TAH) combination versus telmisartan/amlodipine (TA) combination in patients with essential hypertension that did not respond